SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 5,359.65 |
Enterprise Value ($M) | 6,078.74 |
Book Value ($M) | -690.98 |
Book Value / Share | -1.00 |
Price / Book | -7.76 |
NCAV ($M) | -895.94 |
NCAV / Share | -1.30 |
Price / NCAV | -5.98 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.94 |
Return on Assets (ROA) | -1.75 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.64 |
Current Ratio | 3.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 195.72 |
Assets | 400.68 |
Liabilities | 1,091.66 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.62 |
Operating Income | -361.36 |
Net Income | -583.20 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -366.76 |
Cash from Investing | -30.47 |
Cash from Financing | 558.34 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Cambridge Equities, LP | 83.50 | 7.07 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,221,642 | 4,138,342 | 29.52 | |
1,191,176 | 4,205,950 | 28.32 | |
1,130,036 | 4,694,768 | 24.07 | |
2,088,802 | 6,866,991 | 30.42 | |
1,597,262 | 6,184,298 | 25.83 | |
(click for more detail) |
Similar Companies | |
---|---|
HLVX – HilleVax, Inc. | HOWL – Werewolf Therapeutics, Inc. |
HUMA – Humacyte, Inc. | IDXX – IDEXX Laboratories, Inc. |
IDYA – IDEAYA Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io